2-(1H-pyrrol-1-yl)-1,3-thiazole-4-carboxylic acid, 95.0%, 1g

2-Ethylpyrrole>96.0%(GC)1g

(S)-1-(3-Fluorophenyl)-N-methylethanamine, 97%, 100mg

2-Chloro-4-nitroaniline, 95.0%, 100g

Ethyl 2-cyano-2-(2-nitro-4-(trifluoromethyl)phenyl)acetate, 95%, 2g

4-(Benzylamino)piperidine, 500mg

Ethyl 4-(5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-2-methylbenzoate, 98%, 1g

1-Cyclohexyl-[1,4]diazepane, 90.0%, 1g

3-Bromo-2-cyanopyridine, 98.0%, 500g

1-(3,4-diethoxyphenyl)ethanone, 95.0%, 10g

2-Phenylpropan-2-yl Benzodithioate>98.0%(HPLC)1g

N-(4-Benzyloxytrityl)-N'-(2-nitrobenzenesulfonyl)-1,2-diaminoethane Resin cross-linked with 1% DVB (200-400mesh) (0.9-1.1mmol/g)1g

Benzyl 4-bromobutanoate, 95.0%, 10g